<DOC>
	<DOCNO>NCT02054013</DOCNO>
	<brief_summary>Benign prostatic hyperplasia ( BPH ) prevalent entity , affect 50 % men old 60 year . The clinical picture disease include low urinary tract symptom interrupt weak urinary stream , nocturia , urgency leak even sexual dysfunction individual . Medical therapy usually first-line treatment . However , efficacy drug like alpha-blocker limited , disease progress invasive treatment option take consideration . In case moderate severe low urinary tract symptom ( LUTS ) transurethral resection prostate ( TUR-P ) standard treatment . TURP , however , limited prostate small 60-80ml procedure associate complication rate . The cumulative short-term morbidity rate around 11 % necessity surgical revision high 6 % . Bleeding require transfusion transurethral resection syndrome represent potentially serious threat elderly frail patient . Prostatic artery embolization ( PAE ) suggest minimal invasive alternative procedure , perform outpatient set rapid recovery low morbidity . The investigator hypothesize PAE non-inferior treatment symptomatic BPH compare conventional establish TUR-P .</brief_summary>
	<brief_title>Prostatic Artery Embolization v . Conventional Transurethral Prostatectomy Treatment Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Men old 40 Patient must candidate TURP Refractory medical therapy patient willing consider ( ) medical treatment Patient prostate size least 25 ml 80 ml , measure ultrasound IPSS ≥8 QoL ≥3 Qmax &lt; 12 and/or urinary retention Written inform consent Mild symptom ( IPSS &lt; 8 ) Severe atherosclerosis Severe tortuosity aortic bifurcation internal iliac artery Acontractile detrusor Neurogenic low urinary tract dysfunction Urethral stenosis Bladder diverticulum Bladder stone surgical indication Allergy intravenous contrast medium Contraindication MRI image Preinterventionally prove adenocarcinoma prostate Renal failure ( GFR &lt; 60ml/min )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>